Table 3.
Multivariate analysis for the risk of relapse or death among patient with adult Ph- ALL.
Variable | Hazard ratio (95% CI) | P |
---|---|---|
Risk of relapse or death | ||
Age | 1.01 (1.01-1.02) | 0.03 |
WBC | 1.24 (1.04-1.38) | 0.01 |
Platelet count | 1.20 (1.04-1.38) | 0.01 |
Performance status ≥ 2 | 1.81 (1.12-2.92) | 0.02 |
Ho-Tr | 2.65 (1.28-5.52) | 0.01 |
Complex karyotype | 2.58 (1.39-4.80) | < 0.01 |
MRD positive | 1.82 (1.24-2.68) | < 0.01 |
Risk of death | ||
Age | 1.02 (1.01-1.03) | < 0.01 |
WBC | 1.17 (1.01-1.36) | 0.04 |
Performance status ≥ 2 | 1.72 (1.03-2.86) | 0.04 |
Ho-Tr | 3.15 (1.40-7.09) | 0.01 |
Complex karyotype | 2.42 (1.26-4.66) | 0.01 |
MRD positive | 1.93 (1.27-2.92) | < 0.01 |
Ho-Tr, Low hpodiploidy/near-triploidy. WBC and platelet count were analyzed as log (WBC) and log (platelet). Decreased performance status was defined as ECOG PS ≥ 2. All cytogenetic subgroups were compared to the diploid subgroup.